Cargando…
Prevention over screening for ovarian cancer in patients with high-risk germline mutations: Misinterpreting the findings of ALDO
In November 2022, the findings of the Avoiding Late Diagnosis of Ovarian cancer (ALDO) study were published. Subsequent media coverage suggested that investigators had found a safe alternative to risk-reducing bilateral salpingoophorectomy (rrBSO) in patients with pathogenic BRCA1 and BRCA2 germline...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020112/ https://www.ncbi.nlm.nih.gov/pubmed/36938343 http://dx.doi.org/10.1016/j.gore.2023.101157 |